C117H136ClN45O22 — CID 159838309
2-(6-aminopurin-9-yl)-5-[[2-(6-aminopurin-9-yl)ethylamino]methyl]oxolane-3,4-diol;2-(6-aminopurin-9-yl)-5-[(2-carbazol-9-ylethylamino)methyl]oxolane-3,4-diol;N-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]adamantane-1-carboxamide;N-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-2-(4-chlorophenyl)acetamide;N-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-2-(4-methoxyphenyl)acetamide;2-(6-aminopurin-9-yl)-5-[(2-imidazo[4,5-c]pyridin-3-ylethylamino)methyl]oxolane-3,4-diol (PubChem CID 159838309) has the molecular formula C117H136ClN45O22 and a molecular weight of 2560.12 g/mol. Its IUPAC name is 2-(6-aminopurin-9-yl)-5-[[2-(6-aminopurin-9-yl)ethylamino]methyl]oxolane-3,4-diol;2-(6-aminopurin-9-yl)-5-[(2-carbazol-9-ylethylamino)methyl]oxolane-3,4-diol;N-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]adamantane-1-carboxamide;N-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-2-(4-chlorophenyl)acetamide;N-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-2-(4-methoxyphenyl)acetamide;2-(6-aminopurin-9-yl)-5-[(2-imidazo[4,5-c]pyridin-3-ylethylamino)methyl]oxolane-3,4-diol.
| Compound Name | 2-(6-aminopurin-9-yl)-5-[[2-(6-aminopurin-9-yl)ethylamino]methyl]oxolane-3,4-diol;2-(6-aminopurin-9-yl)-5-[(2-carbazol-9-ylethylamino)methyl]oxolane-3,4-diol;N-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]adamantane-1-carboxamide;N-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-2-(4-chlorophenyl)acetamide;N-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-2-(4-methoxyphenyl)acetamide;2-(6-aminopurin-9-yl)-5-[(2-imidazo[4,5-c]pyridin-3-ylethylamino)methyl]oxolane-3,4-diol |
|---|---|
| PubChem CID | 159838309 |
| Molecular Formula | C117H136ClN45O22 |
| Molecular Weight | 2560.12 g/mol |
| Exact Mass | 2558.06 |
| IUPAC Name | 2-(6-aminopurin-9-yl)-5-[[2-(6-aminopurin-9-yl)ethylamino]methyl]oxolane-3,4-diol;2-(6-aminopurin-9-yl)-5-[(2-carbazol-9-ylethylamino)methyl]oxolane-3,4-diol;N-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]adamantane-1-carboxamide;N-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-2-(4-chlorophenyl)acetamide;N-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-2-(4-methoxyphenyl)acetamide;2-(6-aminopurin-9-yl)-5-[(2-imidazo[4,5-c]pyridin-3-ylethylamino)methyl]oxolane-3,4-diol |
| SMILES | COc1ccc(CC(=O)NCC2OC(n3cnc4c(N)ncnc43)C(O)C2O)cc1.Nc1ncnc2c1ncn2C1OC(CNC(=O)C23CC4CC(CC(C4)C2)C3)C(O)C1O.Nc1ncnc2c1ncn2C1OC(CNC(=O)Cc2ccc(Cl)cc2)C(O)C1O.Nc1ncnc2c1ncn2C1OC(CNCCn2c3ccccc3c3ccccc32)C(O)C1O.Nc1ncnc2c1ncn2C1OC(CNCCn2cnc3ccncc32)C(O)C1O.Nc1ncnc2c1ncn2CCNCC1OC(n2cnc3c(N)ncnc32)C(O)C1O |
| InChI | InChI=1S/C24H25N7O3.C21H28N6O4.C19H22N6O5.C18H19ClN6O4.C18H21N9O3.C17H21N11O3/c25-22-19-23(28-12-27-22)31(13-29-19)24-21(33)20(32)18(34-24)11-26-9-10-30-16-7-3-1-5-14(16)15-6-2-4-8-17(15)30;22-17-14-18(25-8-24-17)27(9-26-14)19-16(29)15(28)13(31-19)7-23-20(30)21-4-10-1-11(5-21)3-12(2-10)6-21;1-29-11-4-2-10(3-5-11)6-13(26)21-7-12-15(27)16(28)19(30-12)25-9-24-14-17(20)22-8-23-18(14)25;19-10-3-1-9(2-4-10)5-12(26)21-6-11-14(27)15(28)18(29-11)25-8-24-13-16(20)22-7-23-17(13)25;19-16-13-17(23-7-22-16)27(9-25-13)18-15(29)14(28)12(30-18)6-21-3-4-26-8-24-10-1-2-20-5-11(10)26;18-13-9-15(23-4-21-13)27(6-25-9)2-1-20-3-8-11(29)12(30)17(31-8)28-7-26-10-14(19)22-5-24-16(10)28/h1-8,12-13,18,20-21,24,26,32-33H,9-11H2,(H2,25,27,28);8-13,15-16,19,28-29H,1-7H2,(H,23,30)(H2,22,24,25);2-5,8-9,12,15-16,19,27-28H,6-7H2,1H3,(H,21,26)(H2,20,22,23);1-4,7-8,11,14-15,18,27-28H,5-6H2,(H,21,26)(H2,20,22,23);1-2,5,7-9,12,14-15,18,21,28-29H,3-4,6H2,(H2,19,22,23);4-8,11-12,17,20,29-30H,1-3H2,(H2,18,21,23)(H2,19,22,24) |
| InChIKey | NOJBGBJWTKHECO-UHFFFAOYSA-N |
| XLogP | -1.68 |
| TPSA | 953.74 Ų |
| H-Bond Donors | 25 |
| H-Bond Acceptors | 64 |
| Rotatable Bonds | 33 |
| Heavy Atoms | 185 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2560.12 |
| LogP ≤ 5 | -1.68 |
| H-Bond Donors ≤ 5 | 25 |
| H-Bond Acceptors ≤ 10 | 64 |
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|